Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BERGMAN

Showing results (741-750 of 784) with videos related to

Pageof 79
Sort By:
Gut|October 26, 2021
Duodenal <i>Anaerobutyricum soehngenii</i> infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over studyAnnefleur Koopen, Julia Witjes, Koen Wortelboer, et al.
Nature Communications|August 20, 2016
Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagusPierre Martinez, Margriet R Timmer, Chiu T Lau, et al.
Inflammatory Bowel Diseases|December 31, 2015
Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC StudyAntoine Racine, Franck Carbonnel, Simon S M Chan, et al.
Gastrointestinal Endoscopy|March 15, 2022
Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinomaEsther A Nieuwenhuis, Sanne N van Munster, Sybren L Meijer, et al.
Nucleic Acids Research|November 17, 2007
ORegAnno: an open-access community-driven resource for regulatory annotationObi L Griffith, Stephen B Montgomery, Bridget Bernier, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Endoscopy|June 1, 2021
Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasiaSanne N van Munster, Charlotte N Frederiks, Esther A Nieuwenhuis, et al.
Trials|November 5, 2021
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trialBastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.
European Urology Oncology|October 1, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA AnalysisKaran Parekh, Kim van der Zande, Sarah W S Ng, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Pageof 79

Showing results (741-750 of 784) with videos related to

Sort By:
Pageof 79
Gut|October 26, 2021
Duodenal <i>Anaerobutyricum soehngenii</i> infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over studyAnnefleur Koopen, Julia Witjes, Koen Wortelboer, et al.
Nature Communications|August 20, 2016
Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagusPierre Martinez, Margriet R Timmer, Chiu T Lau, et al.
Inflammatory Bowel Diseases|December 31, 2015
Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC StudyAntoine Racine, Franck Carbonnel, Simon S M Chan, et al.
Gastrointestinal Endoscopy|March 15, 2022
Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinomaEsther A Nieuwenhuis, Sanne N van Munster, Sybren L Meijer, et al.
Nucleic Acids Research|November 17, 2007
ORegAnno: an open-access community-driven resource for regulatory annotationObi L Griffith, Stephen B Montgomery, Bridget Bernier, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Endoscopy|June 1, 2021
Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasiaSanne N van Munster, Charlotte N Frederiks, Esther A Nieuwenhuis, et al.
Trials|November 5, 2021
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trialBastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.
European Urology Oncology|October 1, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA AnalysisKaran Parekh, Kim van der Zande, Sarah W S Ng, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Pageof 79